The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I/II study of eribulin mesilate (ERI) plus irinotecan (IRI) in children with refractory or recurrent solid tumors.
 
Michela Casanova
Consulting or Advisory Role - Bayer; Halozyme; Lilly; Merck; Roche; Tesaro
Travel, Accommodations, Expenses - Bayer; Roche
 
Christof Kramm
Honoraria - Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Novocure (Inst); Novocure (Inst)
Consulting or Advisory Role - Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst)
Research Funding - Boehringer Ingelheim; Boehringer Ingelheim; Novartis; Novartis
Travel, Accommodations, Expenses - Boehringer Ingelheim; Boehringer Ingelheim; Novocure; Novocure
 
Dirk Reinhardt
Consulting or Advisory Role - Abbvie; Bluebird Bio; Boehringer Ingelheim; Janssen; Jazz Pharmaceuticals; MSD; Novartis; Roche
Speakers' Bureau - Bluebird Bio
Research Funding - CLS; Jazz Pharmaceuticals; Roche
 
Franco Locatelli
No Relationships to Disclose
 
David R. D'Adamo
Employment - Eisai
Travel, Accommodations, Expenses - Eisai
 
Rachael Scott
Employment - Eisai
Research Funding - Eisai
 
Yan Jia
Employment - Eisai
Travel, Accommodations, Expenses - Eisai
 
Jagadeesh Aluri
Employment - Eisai
 
Claudio Favre
Speakers' Bureau - Takeda
 
Francisco Bautista
No Relationships to Disclose
 
Raquel Hladun Alvaro
No Relationships to Disclose
 
Ana Sastre Urgelles
Consulting or Advisory Role - Novartis
Speakers' Bureau - Novartis
 
Udo Kontny
Consulting or Advisory Role - Eisai